ResMed Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q42026 FY2026 | $2.90 | — | — | Miss |
| Q32026 FY2026 | $2.79 | $2.86 | +2.5% | Beat |
| Q22026 FY2026 | $2.69 | $2.81 | +4.5% | Beat |
Back to RMD overview · RMD holders · RMD KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.